Revvity | PKI - 股本和储备

股票价格
94.80
每天变化
-1.07 -1.12%
每月一次
0.56%
每年
5.53%
Q2 预测
92.08


金融业
股票价格
USD
资产
USD 12B
现金及等价物
USD 860.32M
销售成本
USD 323.46M
流动资产
USD 2.13B
流动负债
USD 1.24B
债务
USD 3.4B
股息收益率
0.32
EBIT
USD 82.77M
EBITDA
USD 272.91M
员工
11K
EPS每股收益
USD 1.06
股本和储备
USD 7.25B
销售毛利
USD 387.66M
债务利息支出
USD 24.72M
利息收入
USD 5.75M
贷款资金
USD 2.63B
市值
USD 11.71B
净收入
USD 40.72M
营业费用
USD 628.35M
营业利润
USD 82.77M
普通股股本
USD 111.8M
PE价格收益
30.79
税前利润
USD 91.56M
销售收入
USD 711M
销售和管理费用
USD 253.88M
股票
USD 387.51M
贸易债权人
USD 169.68M
应收帐款人
USD 691.38M


股本和储备 更改 日
Agilent USD 6.91B 167M 2025-12
Align Technology USD 4.15B 100.27M 2026-03
Bio Techne USD 2.09B 74.32M 2026-03
Bio-Rad Laboratories USD 6.85B 602.3M 2026-03
Bruker USD 2.46B 35.9M 2025-12
Celltrion KRW 435.96B 16.26T 2025-12
Charles River Laboratories USD 2.9B 265.94M 2026-03
Cspc Pharmaceutical CNY 33.18B 71.46M 2025-12
Danaher USD 52.95B 415M 2026-03
Dentsply International USD 1.32B 21M 2026-03
Deva Holding AS TRY 5.79B 604.07M 2023-09
Dianthus Therapeutics USD 1.2B 707.91M 2026-03
Divis Laboratories Ltd INR 154.13B 4.44B 2025-09
Edwards Lifesciences USD 10.33B 10.1M 2026-03
Illumina USD 2.68B 47M 2026-03
Intuitive Surgical USD 17.47B 349.5M 2026-03
IQVIA Holdings USD 6.22B 282M 2026-03
Kangmei Pharma CNY 7.22B 504.3M 2025-09
Knight Therapeutics CAD 767.27M 480K 2025-12
Laboratorios Farma EUR 539.39M 22.74M 2023-12
Laboratory Of America USD 8.73B 108.8M 2026-03
Malin Corporation EUR 193.2M 75M 2024-12
Medical Developments International AUD 54.77M 335K 2025-12
Mesa Laboratories USD 186.69M 8.22M 2025-12
Mettler Toledo International USD -41.88M 18.25M 2026-03
Myriad Genetics USD 337.4M 30.6M 2026-03
Neuren Pharmaceuticals AUD 338.45M 15.18M 2025-12
OraSure Technologies USD 313.32M 27.5M 2026-03
Organigram Holdings CAD 369.46M 20.33M 2025-12
Ovoca Bio EUR 1.26M 7.41M 2025-06
Pacific Biosciences Of California USD 2.37M 2.98M 2026-03
Pharma Mar EUR 249.67M 2.16M 2026-03
Qiagen NV USD 3.78B 128.73M 2025-12
Quest Diagnostics USD 7.37B 196M 2026-03
Quidel USD 1.85B 69.1M 2026-03
Repligen USD 2.11B 666K 2026-03
Revvity USD 7.25B 125.54M 2025-12
Sartorius EUR 2.73B 1.14B 2026-03
Sino Biopharmaceutical CNY 34B 1.48B 2025-06
Thermo Fisher Scientific USD 51.93B 1.6B 2026-03
Tilray USD 1.58B 39.08M 2025-09
Waters USD 2.56B 230.55M 2025-12
Zealand Pharma A/S 14.83B 331.99M 2025-12
Zz Pientze Pharmaceu CNY 15.21B 740.32M 2026-03